SCHEMBL13304510

SCHEMBL13304510

CCOC(=O)c1cnc(N2CCC(Cn3ccn(-c4ccc(F)cc4)c3=O)CC2)nc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OGA O60502 1/20 0.40
THRB P10828 1/20 0.39
KDM1A O60341 4/20 0.39
HDAC6 Q9UBN7 4/20 0.39
DPP4 P27487 1/20 0.38
DPP8 Q6V1X1 1/20 0.38
DPP9 Q86TI2 1/20 0.38
DPP7 Q9UHL4 1/20 0.38
GABRA2 P47869 1/20 0.38
GABRB2 P47870 1/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
ALDH1A1 P00352 2/20 0.38
P2RY12 Q9H244 1/20 0.37
HSP90AA1 P07900 1/20 0.37
MAPT P10636 1/20 0.37
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.37
RAB9A P51151 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13304505 0.90 HDAC6 (0.40) OGAHDAC6GABRA2GABRB2KMT2A
SCHEMBL13304500 0.88 MEN1 (0.42) OGAHDAC6KMT2AMEN1ALDH1A1
SCHEMBL13304511 0.87 HDAC6 (0.42) KDM1AHDAC6KMT2AMEN1DEGS1
SCHEMBL13304561 0.84 HDAC6 (0.55) KDM1AHDAC6
SCHEMBL13304524 0.82 HDAC6 (0.43) OGAHDAC6P2RY12MAPTLMNA
SCHEMBL13304596 0.79 HDAC6 (0.51) KDM1AHDAC6
SCHEMBL13304514 0.77 HDAC6 (0.39) KDM1AHDAC6ALDH1A1DEGS1
SCHEMBL13304593 0.77 KDM1A (0.57) KDM1AHDAC6
SCHEMBL13304506 0.77 HDAC6 (0.44) KDM1AHDAC6ALDH1A1HRH3
SCHEMBL13304501 0.76 HTT (0.41) HDAC6KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160321-A1 IMIDAZOLINONE AND HYDANTOINE DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE JANSSEN PHARMACEUTICA N.V. (BE) 2010-06-24 US disclosed
US-20100160321-A1 IMIDAZOLINONE AND HYDANTOINE DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE JANSSEN PHARMACEUTICA N.V. (BE) 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160321-A1 IMIDAZOLINONE AND HYDANTOINE DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC2, HDAC3 OGA 3002/4885THRB 3536/4885KDM1A 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.